However, the panel recognized that these resources may not be available in all health care settings, and that the key is for the treating provider (who could be the treating physician) to educate the patient and implement a treat-to-target protocol. Duration of ULT Continuing ULT indefinitely over stopping ULT is conditionally recommended. For patients in clinical remission taking ULT (e.g., no flares for â‰¥1 year and no tophi Recommendations for patients receiving ULT medications Allopurinol